Ranolazine is an antianginal drug and a class V antiarrhythmic drug that is mainly used for the treatment of chronic angina. Ranolazine is also used off-label to treat certain arrhythmias, including ...

Palo Alto, California Fears over QT prolongation are mounting for a range of already approved drugs, as well as for agents still in the pipeline. This past week, ranolazine, CV Therapeutics' new ...

Co announces that data published in Circulation and presented at the European Society of Cardiology Congress 2007 in Vienna shows that Ranexa reduced both ventricular and atrial arrhythmias in ...

SAN FRANCISCO, CA — Researchers presenting new findings on a potential fixed-dose drug combination for a common arrhythmia allowed themselves a good measure of optimism, perhaps an indulgence given ...